Trial · NCT00355082
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind (DB) Treatment Phase | STARTED | Lamotrigine Extended-release (LTG XR), 300 mg | 113 | |
| Double-Blind (DB) Treatment Phase | STARTED | LTG XR, 250 mg | 113 | |
| Double-Blind (DB) Treatment Phase | STARTED | Baseline Failures | 0 | |
| Double-Blind (DB) Treatment Phase | COMPLETED | Lamotrigine Extended-release (LTG XR), 300 mg | 94 | |
| Double-Blind (DB) Treatment Phase | COMPLETED | LTG XR, 250 mg | 79 | |
| Double-Blind (DB) Treatment Phase | COMPLETED | Baseline Failures | 0 | |
| Double-Blind (DB) Treatment Phase | NOT COMPLETED | Lamotrigine Extended-release (LTG XR), 300 mg | 19 | |
| Double-Blind (DB) Treatment Phase | NOT COMPLETED | LTG XR, 250 mg | 34 | |
| Double-Blind (DB) Treatment Phase | NOT COMPLETED | Baseline Failures | 0 | |
| Continuation Phase | STARTED | Lamotrigine Extended-release (LTG XR), 300 mg | 184 | |
| Continuation Phase | STARTED | LTG XR, 250 mg | 0 | |
| Continuation Phase | STARTED | Baseline Failures | 11 | |
| Continuation Phase | COMPLETED | Lamotrigine Extended-release (LTG XR), 300 mg | 160 | |
| Continuation Phase | COMPLETED | LTG XR, 250 mg | 0 | |
| Continuation Phase | COMPLETED | Baseline Failures | 8 | |
| Continuation Phase | NOT COMPLETED | Lamotrigine Extended-release (LTG XR), 300 mg | 24 | |
| Continuation Phase | NOT COMPLETED | LTG XR, 250 mg | 0 | |
| Continuation Phase | NOT COMPLETED | Baseline Failures | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00355082/flow